Local Recurrence of Metastatic Brain Tumor after Stereotactic Radiosurgery or Surgery Plus Radiation
Tóm tắt
In this study, we compared the recurrence of metastatic brain tumors after radiosurgery versus after surgery plus radiation, and analyzed the factors associated with the recurrence of brain metastases. Twenty-eight and 35 patients with metastatic brain tumors underwent radiosurgery (52 lesions) and surgery plus radiation (46 lesions), respectively, between 1995 and 2001. The median tumor volume was 1.55 ml (range: 0.02–10.4 ml) in radiosurgery patients and 17.9 ml (range: 0.26–195 ml) in surgery plus radiation patients. The median radiosurgical tumor central and margin doses were 28.9 and 23.8 Gy (range: 20–35 and 25–15 Gy), respectively. The median total dose was 46.7 Gy (range: 30–63 Gy) in the surgery plus radiation group. The recurrence time from surgery plus radiation group (25 months) was significantly longer than that from the radiosurgery group (7.2 months) (p=0.0199). The factors affecting the recurrence of brain metastases after radiosurgery were size, central dose of radiation and histology (colon vs. others). No factors affected the recurrence of brain metastases after surgery plus radiation. To avoid early recurrences of metastatic brain tumors, surgery plus radiation is the preferable therapeutic modality. The size and histology of brain metastases, and the dose of radiation should be considered for the effective treatment of tumors by radiosurgery.
Tài liệu tham khảo
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500, 1990
Engenhart R, Kimmig BN, Hover KH, Wowra B, Romahn J, Lorenz WJ, van Kaick G, Wannenmacher M: Longterm follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71: 1353–1361, 1993
Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR IV, Sneed PK, Larson DA: A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28: 797–802, 1994
Bindal AK, Bindal RK, Hess KR, Shiu A, Hassenbusch SJ, Shi WM, Sawaya R: Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 84: 748–754, 1996
Flickinger JC, Kondziolka D: Radiosurgery instead of resection for solitary brain metastasis: the gold standard rede-fined. Int J Radiat Oncol Biol Phys 35: 185–186, 1996
Cox DR: Regression models and life tables. J R Stat Soc 74: 187–220, 1972
Chen JCT, Petrovich Z, O'Day S, Morton D, Essner R, Giannotta SL, Yu C, Apuzzo MLJ: Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery 47: 268–281, 2000
Noordijk E, Vecht C, Haaxma-Reiche H, Padberg G, Voomolen J, Hoekstra FH, Tans J, Lambooij N, Metsaars J, Wattendorf A, Brand R, Hermans J: The choice of treatment of single brain metastasis should be based on extracranial activity and age. Int J Radiat Oncol Biol Phys 29: 711–717, 1994
Mehta M, Noyes W, Craig B, Lamond J, Auchter R, French M, Johnson M, Levin A, Badie B, Robbins I, Kinsella T: A cost-effectiveness and cost-utility analysis of radiosurgery versus resection for single-brain metastases. Int J Radiat Oncol Biol Phys 39: 445–454, 1997
Rutigliano MJ, Lunsford LD, Kondziolka D, Strauss MJ, Khanna V, Green M: The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 37: 445–455, 1995
Amalric R, Santamaria F, Robert F, Seigle J, Altschuler C, Kurtz JM, Spitalier JM, Brandone H, Ayme Y, Pollet JF, Burmeister R, Abed R: Radiation therapy with or without primary limited surgery for operable breast cancer: a 20–year experience at the Marseilles Cancer Institute. Cancer 49: 30–34, 1982
The Lung Cancer Study Group: Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 315: 1377–1381, 1986
Zucali R, Uslenghi C, Kenda R, et al.: Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer 37: 1422–1431, 1976
Gastrointestinal Tumor Study Group: Prolongation of the disease free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472, 1985
Suzuki M, Takashima T, Kadoya M, Ueda T, Arakawa F, Ueda F, Yamashita J, Yamashita T, Nonomura A: Signal intensity of brain metastases on T2–weighted images: speci-ficity for metastases from colonic cancers. Neurochirurgia (stuttg) 36: 151–155, 1993
Shiau CY, Sneed PK, Shu HK, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PH, Larson DA: Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37: 375–383, 1997
Matsuo T, Shibata S, Yasunaga A, Iwanaga M, Mori K, Shimizu T, Hayashi N, Ochi M, Hayashi K: Dose optimization and indication of linac radiosurgery for brain metastasis. Int J Radiat Oncol Biol Phys 45: 931–939, 1999
Alexander E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87: 34–40, 1995
Muacevic A, Kreth FW, Horstmann GA, Schmid-Elsaesser R, Wowra B, Steiger HJ, Reulen HJ: Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 91: 35–43, 1999